Study of Immunomechanisms in HTLV-I-Associated Myelopathy(HAM)
HTLV-I相关性脊髓病(HAM)的免疫机制研究
基本信息
- 批准号:63480217
- 负责人:
- 金额:$ 4.03万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1988
- 资助国家:日本
- 起止时间:1988 至 1990
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Purpose :To clarify the pathogenesis of HTLV-I-associated myelopathy (HAM), we studied several immunological abnormalities which were frequently observed in the patients and were thought to be changes characteristic of this disease. In this study, we mainly studied (1) an alteration of subsets of the peripheral blood mononuclear cells (PBMNC), (2) a great increase in spontaneous proliferation of the peripheral blood lymphocytes (PBL), and (3) cellular immune surveillance against increased HTLV-I infected cells in the peripheral circulation of the patients.Results :(1) Subsets of PBMNC ; We found a significant increase in activated T-lymphocytes (CD25+CD3+ cells, CD4+DR+ cells and CD8+DR+ cells) and helper inducer T-lymphocytes (CD4+CD29+ cells) in the peripheral blood of HAM patients. This increase in activated T-lymphocytes and helper T-lymphocytes became more prominant when PBMNC were cultured in a short term. There were decreases in several subsets of NK cells, such as CD16+ cells, … More CD56+ cells and CD16+CD3+ cells.(2) Study of an increased spontaneous PBL proliferation ; We observed a great increase in spontaneous PBL proliferation (SPP) in a short-term culture of PBMNC from HAM patients, without any mitogens or antigens. In the suppression study of the SPP, either the sera from patients or monoclonal antibodies (mAb) to HTLV-I did not suppress the increased SPP. In contrast, mAb to IL-2R (CD25) and cyclosporin A (an inhibitor of IL-2 production) showed strong suppression effects on SPP.(3) Cellular immune surveillance against HTLV-I infected cells ; We observed that HTLV-I proviral DNA was significantly increased in PBMNC from HAM patients compared with those from HTLV-I carriers. To evaluate an ability of the cellular immune surveillance against HTLV-I infected cells, we studied NK activity and CTL and ADCC activities against HTLV-I infected cells. Although CTL activity was significantly higher in HAM patients than in carriers, NK and ADCC activities were significantly decreased in the patients.Conclusions :In the peripheral circulation of HAM patients, HTLV-I infected cells were increased and T-lymphocytes were found in highly activated state. A great increase in SPP is a characteristic change observed in HAM, and the SPP may induce several autoreactive T-cell clones reactive to CNS tissue. Less
目的:为了阐明HTLV-Ⅰ相关性脊髓病(HAM)的发病机制,我们研究了患者中常见的几种免疫学异常,这些异常被认为是这种疾病的特征性变化。本研究主要研究了(1)患者外周血单个核细胞(PBMNC)亚群的变化,(2)患者外周血淋巴细胞(PBL)自发性增殖的显著增加,(3)患者外周循环中HTLV-Ⅰ感染细胞的细胞免疫监视。我们发现HAM患者外周血中活化T淋巴细胞(CD 25 + CD 3+细胞、CD 4 +DR+细胞和CD 8 +DR+细胞)和辅助诱导T淋巴细胞(CD 4 + CD 29+细胞)显著增加。在短期内培养PBMNC时,活化T淋巴细胞和辅助T淋巴细胞的增加变得更加明显。NK细胞的几个亚群,如CD 16+细胞, ...更多信息 CD 56+细胞和CD 16 + CD 3+细胞。(2)PBL自发性增殖增加的研究:我们观察到HAM患者PBMNC在短期培养中的自发性PBL增殖(SPP)显著增加,没有任何促分裂原或抗原。在SPP的抑制研究中,无论是患者血清还是抗HTLV-Ⅰ的单克隆抗体(mAb)都不能抑制SPP的升高。而抗IL-2 R(CD 25)单克隆抗体和IL-2产生抑制剂环孢菌素A(cyclosporin A)对SPP有较强的抑制作用。(3)对HTLV-I感染细胞的细胞免疫监视:我们观察到HTLV-I前病毒DNA显着增加,从HAM患者的PBMNC相比,从HTLV-I携带者。为了评价细胞免疫监视对HTLV-I感染的细胞的能力,我们研究了NK活性和对HTLV-I感染的细胞的CTL和ADCC活性。结论:HAM患者外周血中HTLV-Ⅰ型感染细胞增多,T淋巴细胞处于高度活化状态。SPP的大量增加是在HAM中观察到的特征性变化,并且SPP可以诱导几种对CNS组织反应的自身反应性T细胞克隆。少
项目成果
期刊论文数量(80)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Minato,S.: "Activated T cells in HTLVーIーassociated myelopathy:Autologous mixed lymphocyte reaction." Ann.Neurol.26. 398-401 (1989)
Minato, S.:“HTLV-I 相关脊髓病中的活化 T 细胞:自体混合淋巴细胞反应。”Ann.Neurol.26 (1989)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Itoyama,Y.: "Oncogenic Herpesviruses Recent advances in Japan:Antibody titers to EpsteinーBarr virus in HTLVーI associated myelopathy(HAM)." Hokkaido University Medical Library Series Vol 24, 8 (1988)
Itoyama, Y.:“日本致癌性疱疹病毒的最新进展:HTLV-I 相关脊髓病 (HAM) 中 Epstein-Barr 病毒的抗体滴度。北海道大学医学图书馆系列,第 24 卷,第 8 卷(1988 年)”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Itoyama,Y.: "Neurology and Neurobiology:HTLVーI and the Nervous System:Immunological Aspects of HTLVーIーAssociated Myelopathy(HAM)" Alan R.Liss Inc.New York, 9 (1989)
Itoyama, Y.:“神经学和神经生物学:HTLV-I 和神经系统:HTLV-I 相关脊髓病 (HAM) 的免疫学方面”Alan R.Liss Inc.New York,9 (1989)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yu, F.: "Natural killer (NK) cells in HTLV-I-associated myelopathy / tropical spastic paraparesis- Decrease in NK subset populations and activity in HTLV-I seropositive individuals-" J. Neuroimmunol.
Yu, F.:“HTLV-I 相关脊髓病/热带痉挛性截瘫中的自然杀伤 (NK) 细胞 - HTLV-I 血清阳性个体中 NK 亚群数量和活性的减少 -”J. Neuroimmunol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Minato S.: "Expression of HTLV-I antigen in cultured peripheral blood mononuclear cells from patients with HTLV-I associated myelopathy." J.Neurol.Sci.87. 233-244 (1988)
Minato S.:“HTLV-I 相关脊髓病患者培养的外周血单核细胞中 HTLV-I 抗原的表达。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ITOYAMA Yasuto其他文献
ITOYAMA Yasuto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ITOYAMA Yasuto', 18)}}的其他基金
Establishment of a new disease entity as astrocytopathy, and studies on the pathogenesis and treatment for neuromyelitis optica
星形细胞病新病种的建立及视神经脊髓炎的发病机制和治疗研究
- 批准号:
22229008 - 财政年份:2010
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Elucidate the pathomechanism of inclusion body myositis(IBM)
阐明包涵体肌炎(IBM)的发病机制
- 批准号:
22659167 - 财政年份:2010
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Optic-spinal multiple sclerosis : clarification of pathogenesis, establishment of new disease entity and treatment
视脊髓多发性硬化症:发病机制的阐明、新疾病实体的建立和治疗
- 批准号:
19209032 - 财政年份:2007
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A Study on the Pathogenesis and Therapy of Optic-Spinal Multiple Sclerosis
视神经脊髓多发性硬化症的发病机制及治疗研究
- 批准号:
17390250 - 财政年份:2005
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
COMPARATIVE ANALYSIS OF CLINICAL AND MOLECULAR IMMUNOLOGICAL PATHOGENESES IN SUBTYPES OF MULTIPLE SCLEROSIS IN JAPAN
日本多发性硬化症亚型临床及分子免疫病因比较分析
- 批准号:
15390271 - 财政年份:2003
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Comparative analysis of molecular immunopathogenesis in optic-spinal and conventional multiple sclerosis
视神经脊髓病与传统多发性硬化症分子免疫发病机制的比较分析
- 批准号:
13470131 - 财政年份:2001
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mutational analysis in dysferlin gene in patients with muscular dystrophy in Japanese populations.
日本人群肌营养不良症患者 Dysferlin 基因突变分析。
- 批准号:
12557058 - 财政年份:2000
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Genetic analysis in families with amyotrophic lateral sclerosis
肌萎缩侧索硬化症家族的遗传分析
- 批准号:
11470144 - 财政年份:1999
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Clinical epidemiology and analysis of pathomechanisms of optic-spinal form of multiple sclerosis
视脊髓型多发性硬化症的临床流行病学及发病机制分析
- 批准号:
09470150 - 财政年份:1997
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular genetic study of familial ALS in Japan
日本家族性 ALS 的分子遗传学研究
- 批准号:
07457152 - 财政年份:1995
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Study on the protective factors for total mortality among HTLV-I carriers
HTLV-I携带者总死亡率的保护因素研究
- 批准号:
20K10506 - 财政年份:2020
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of a non-human primate model using cynomolgus monkeys for evaluating anti-HTLV-I mother to child infection drugs.
食蟹猴非人灵长类动物模型的建立,用于评价抗HTLV-I母婴感染药物。
- 批准号:
16K15285 - 财政年份:2016
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia
HTLV-I Tax 和 HBZ 如何控制端粒酶活性以诱导成人 T 细胞白血病
- 批准号:
9513500 - 财政年份:2016
- 资助金额:
$ 4.03万 - 项目类别:
How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia
HTLV-I Tax 和 HBZ 如何控制端粒酶活性以诱导成人 T 细胞白血病
- 批准号:
9304181 - 财政年份:2016
- 资助金额:
$ 4.03万 - 项目类别:
Role of HTLV-I Tax-induced NF-kB in activation of ICN1 and immortalization of vir
HTLV-I Tax诱导的NF-kB在ICN1激活和vir永生化中的作用
- 批准号:
8435077 - 财政年份:2013
- 资助金额:
$ 4.03万 - 项目类别:
Role of HTLV-I Tax-induced NF-kB in activation of ICN1 and immortalization of vir
HTLV-I Tax诱导的NF-kB在ICN1激活和vir永生化中的作用
- 批准号:
8606171 - 财政年份:2013
- 资助金额:
$ 4.03万 - 项目类别:
Elucidation of mechanism for HTLV-I-associated Sjogren's syndrome
阐明 HTLV-I 相关干燥综合征的机制
- 批准号:
25461477 - 财政年份:2013
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The elucidation of the signalings of cytoskeletal reorganization involved in the development of HTLV-I-associated myelopathy
阐明参与 HTLV-I 相关脊髓病发生的细胞骨架重组信号
- 批准号:
24591267 - 财政年份:2012
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of HTLV-I-specific anti-cancer therapy by using single chain T cell receptors and single chain trimers of MHC-I.
利用单链T细胞受体和MHC-I单链三聚体开发HTLV-I特异性抗癌疗法。
- 批准号:
24590547 - 财政年份:2012
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mathematical epidemic models for the rapidly growing infection of HTLV-I
HTLV-I 感染迅速增长的数学流行病模型
- 批准号:
24540137 - 财政年份:2012
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)